17 results on '"Ceribelli, Angela"'
Search Results
2. An Italian Multicenter Study on Anti-NXP2 Antibodies: Clinical and Serological Associations
3. Clinical Significance of Antinucleolar Antibodies: Biomarkers for Autoimmune Diseases, Malignancies, and others
4. Long-term Outcome of Children Born to Women with Autoimmune Rheumatic Diseases: A Multicentre, Nationwide Study on 299 Randomly Selected Individuals
5. MicroRNAs in Axial Spondylarthritis: an Overview of the Recent Progresses in the Field with a Focus on Ankylosing Spondylitis and Psoriatic Arthritis
6. Personalized medicine in rheumatology: the paradigm of serum autoantibodies
7. A Comprehensive Overview on Myositis-Specific Antibodies: New and Old Biomarkers in Idiopathic Inflammatory Myopathy
8. Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis
9. The Immune Response and the Pathogenesis of Idiopathic Inflammatory Myositis: a Critical Review
10. Nailfold videocapillaroscopy and serum VEGF levels in scleroderma are associated with internal organ involvement
11. PFAPA syndrome and Behçet’s disease: a comparison of two medical entities based on the clinical interviews performed by three different specialists
12. The Th17 axis in psoriatic disease: pathogenetic and therapeutic implications
13. Positive Correlation of STAT1 and miR-146a with Anemia in Patients with Systemic Lupus Erythematosus
14. Differential Reactivity to IMPDH2 by Anti-rods/rings Autoantibodies and Unresponsiveness to Pegylated Interferon-alpha/Ribavirin Therapy in US and Italian HCV Patients
15. Suspected and unsuspected factors in the multifaceted immunopathology of viral hepatitis
16. Common Pathways of Autoimmune Inflammatory Myopathies and Genetic Neuromuscular Disorders
17. Gender and ethnicity differences in the prevalence of scleroderma-related autoantibodies
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.